S'abonner

Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma - 05/10/20

Doi : 10.1016/j.jaci.2020.02.031 
Graham Roberts, DM a, b, c, , Sara Fontanella, PhD d, , Anna Selby, DM a, Rebecca Howard, PhD e, Sarah Filippi, PhD f, Gunilla Hedlin, PhD g, Bjorn Nordlund, PhD g, Peter Howarth, DM a, b, Simone Hashimoto, PhD h, i, Peter Brinkman, MSc h, Louise J. Fleming, MD d, j, Clare Murray, MD k, Andrew Bush, MD j, l, Urs Frey, PhD m, Florian Singer, PhD n, Ann-Marie Malby Schoos, MD, PhD l, Wim van Aalderen, PhD i, Ratko Djukanovic, DM a, b, K. Fan Chung, DSc j, Peter J. Sterk, PhD h, Custovic Adnan, MD, PhD, FAAAI d
on behalf of the

U-BIOPRED Consortium

  Other consortium study team members are listed in this article’s Online Repository at www.jacionline.org.

a Clinical and Experimental Sciences and Human Development in Health Academic Unit, University of Southampton Faculty of Medicine, Southampton, United Kingdom 
b NIHR Southampton Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom 
c David Hide Asthma and Allergy Research Centre, St Mary’s Hospital, Newport, Isle of Wight, United Kingdom 
d National Heart and Lung Institute, Imperial College London, London, United Kingdom 
e Division of Informatics, Imaging and Data Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, United Kingdom 
f Department of Mathematics, Imperial College London, London, United Kingdom 
g Department of Women’s and Children’s Health and the Centre for Allergy Research, Karolinska Institutet at Karolinska University Hospital, Stockholm, Sweden 
h Department of Respiratory Medicine, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 
i Department of Paediatric Respiratory Medicine and Allergy, Emma Children’s Hospital, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands 
j Department of Respiratory Paediatrics, Royal Brompton Hospital, London, United Kingdom 
k Division of Infection, Immunity and Respiratory Medicine, The University of Manchester, Manchester Academic Health Science Centre, University Hospital of South Manchester NHS Foundation Trust, Manchester, United Kingdom 
l COPSAC (Copenhagen Prospective Studies on Asthma I Childhood), Herlev and Gentofte Hospital, University of Copenhagen, Copenhagen, Denmark 
m University Children’s Hospital Basel UKBB, University of Basel, Spitalstrasse, Basel, Switzerland 
n Division of Respiratory Medicine, Department of Pediatrics, University Children’s Hospital Bern, University of Bern, Bern, Switzerland 

Corresponding author: Graham Roberts, DM, Paediatric Allergy and Respiratory Medicine (Mailpoint 805), Southampton University Hospital NHS Foundation Trust, Tremona Rd, Southampton SO16 6YD, United Kingdom.Paediatric Allergy and Respiratory Medicine (Mailpoint 805)Southampton University Hospital NHS Foundation TrustTremona RdSouthamptonSO16 6YDUnited Kingdom

Abstract

Background

Allergic sensitization is associated with severe asthma, but assessment of sensitization is not recommended by most guidelines.

Objective

We hypothesized that patterns of IgE responses to multiple allergenic proteins differ between sensitized participants with mild/moderate and severe asthma.

Methods

IgE to 112 allergenic molecules (components, c-sIgE) was measured using multiplex array among 509 adults and 140 school-age and 131 preschool children with asthma/wheeze from the Unbiased BIOmarkers for the PREDiction of respiratory diseases outcomes cohort, of whom 595 had severe disease. We applied clustering methods to identify co-occurrence patterns of components (component clusters) and patterns of sensitization among participants (sensitization clusters). Network analysis techniques explored the connectivity structure of c-sIgE, and differential network analysis looked for differences in c-sIgE interactions between severe and mild/moderate asthma.

Results

Four sensitization clusters were identified, but with no difference between disease severity groups. Similarly, component clusters were not associated with asthma severity. None of the c-sIgE were identified as associates of severe asthma. The key difference between school children and adults with mild/moderate compared with those with severe asthma was in the network of connections between c-sIgE. Participants with severe asthma had higher connectivity among components, but these connections were weaker. The mild/moderate network had fewer connections, but the connections were stronger. Connectivity between components with no structural homology tended to co-occur among participants with severe asthma. Results were independent from the different sample sizes of mild/moderate and severe groups.

Conclusions

The patterns of interactions between IgE to multiple allergenic proteins are predictors of asthma severity among school children and adults with allergic asthma.

Le texte complet de cet article est disponible en PDF.

Key words : Asthma, allergic sensitization, cluster, network analysis

Abbreviations used : CRD, c-sIgE, HDM, ISU, JDINAC, SPT, U-BIOPRED


Plan


 U-BIOPRED is supported through an Innovative Medicines Initiative (IMI) Joint Undertaking under grant agreement number 115010, resources of which are composed of financial contribution from the European Union’s Seventh Framework Programme (FP7/2007-2013) and European Federation of Pharmaceutical Industries and Associations (EFPIA) companies’ in kind contribution (www.imi.europa.eu). The IMI-funded European Translational Information & Knowledge Management Services (eTRIKS) project (European Union grant code no. 115446) also provided help.
 Disclosure of potential conflicts of interest: G. Robert’s University has received honoraria from Thermo Fisher for a sponsored symposium. A.-M. M. Schoos has received a travel grant from Thermo Fisher in the last 3 years. A. Custovic reports personal fees from Thermo Fisher, during the conduct of the study; and personal fees from Novartis, Regeneron, Philips, and Sanofi, outside the submitted work. The rest of the authors declare that they have no relevant conflicts of interest.


© 2020  American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Ajouter à ma bibliothèque Retirer de ma bibliothèque Imprimer
Export

    Export citations

  • Fichier

  • Contenu

Vol 146 - N° 4

P. 821-830 - octobre 2020 Retour au numéro
Article précédent Article précédent
  • Obesity may enhance the adverse effects of NO2 exposure in urban schools on asthma symptoms in children
  • Perdita Permaul, Jonathan M. Gaffin, Carter R. Petty, Sachin N. Baxi, Peggy S. Lai, William J. Sheehan, Carlos A. Camargo, Diane R. Gold, Wanda Phipatanakul
| Article suivant Article suivant
  • Ventilation defects on hyperpolarized helium-3 MRI in asthma are predictive of 2-year exacerbation frequency
  • David G. Mummy, Katherine J. Carey, Michael D. Evans, Loren C. Denlinger, Mark L. Schiebler, Ronald L. Sorkness, Nizar N. Jarjour, Sean B. Fain

Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.

Déjà abonné à cette revue ?

Mon compte


Plateformes Elsevier Masson

Déclaration CNIL

EM-CONSULTE.COM est déclaré à la CNIL, déclaration n° 1286925.

En application de la loi nº78-17 du 6 janvier 1978 relative à l'informatique, aux fichiers et aux libertés, vous disposez des droits d'opposition (art.26 de la loi), d'accès (art.34 à 38 de la loi), et de rectification (art.36 de la loi) des données vous concernant. Ainsi, vous pouvez exiger que soient rectifiées, complétées, clarifiées, mises à jour ou effacées les informations vous concernant qui sont inexactes, incomplètes, équivoques, périmées ou dont la collecte ou l'utilisation ou la conservation est interdite.
Les informations personnelles concernant les visiteurs de notre site, y compris leur identité, sont confidentielles.
Le responsable du site s'engage sur l'honneur à respecter les conditions légales de confidentialité applicables en France et à ne pas divulguer ces informations à des tiers.


Tout le contenu de ce site: Copyright © 2024 Elsevier, ses concédants de licence et ses contributeurs. Tout les droits sont réservés, y compris ceux relatifs à l'exploration de textes et de données, a la formation en IA et aux technologies similaires. Pour tout contenu en libre accès, les conditions de licence Creative Commons s'appliquent.